Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group.
Saved in:
| Title: | Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. |
|---|---|
| Authors: | Chodak, G W1 (AUTHOR), Vogelzang, N J (AUTHOR), Caplan, R J (AUTHOR), Soloway, M (AUTHOR), Smith, J A (AUTHOR) |
| Source: | JAMA: Journal of the American Medical Association. 2/6/91, Vol. 265 Issue 5, p618-621. 4p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
